Journal
Blood Advances
Publication Date
1-13-2026
Volume
10
Issue
1
First Page
217
Last Page
227
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2024015599
Rights and Permissions
Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror M. New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13;10(1):217-227. doi: 10.1182/bloodadvances.2024015599. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Greenbaum, Uri; Cashen, Amanda; and et al., "New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma." Blood Advances. 10, 1. 217 - 227. (2026).
https://digitalcommons.wustl.edu/oa_4/6372
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
